Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-23

Clinical Trial Update: Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating dual trigger in final oocyte maturation for poor ovarian responders has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Poor Ovarian Reserve | Phase 3 | Status: COMPLETED